Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-25 @ 4:19 AM
NCT ID:
NCT03951220
Eligibility Criteria:
Inclusion Criteria (All Groups):
* Participant is able to and willing to give informed consent for participation in the study.
* Male or Female, aged 18 years or above.
Inclusion Criteria (Groups 1 and 2):
* Newly diagnosed myeloma or newly relapsed myeloma eligible for next therapy.
* Smouldering myeloma or intermediate or high risk MGUS.
* Patients attending Oxford NHS Haematology-Oncology centre.
* Diagnoses of MGUS, Smouldering Myeloma and MM made in accordance with the clinical diagnostic criteria set forth by IMWG (International Myeloma Working Group).
Exclusion Criteria (All Groups):
* Those who are unable or unwilling to give informed consent.
* Women who may be pregnant, breast feeding or women of child-bearing potential who are unwilling or unable to take sufficient precautionary measures will be excluded due to DXA imaging.
Exclusion Criteria (Groups 1 and 2):
* Signs of Spinal Cord Compression.
* Patients with documented metastatic lesions from another type of malignancy.
* Known contraindication for a MRI scan, including unacceptable pain on lying flat for 1 hour.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT03951220
Study Brief:
Protocol Section:
NCT03951220